Tempest Therapeutics
TPST
#10989
Rank
NZ$13.82 M
Marketcap
NZ$0.69
Share price
-0.29%
Change (1 day)
-95.81%
Change (1 year)

EPS for Tempest Therapeutics (TPST)

EPS in 2026 (TTM): NZ-$9.76

According to Tempest Therapeutics's latest financial reports the company's current EPS (TTM) is NZ-$10.38. In 2025 the company made an earnings per share (EPS) of NZ-$11.46 an increase over its 2024 EPS that were of NZ-$35.31.

EPS history for Tempest Therapeutics from 2020 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ-$9.76-14.89%
2025NZ-$11.46-67.54%
2024NZ-$35.31-21.47%
2023NZ-$44.96-38.19%
2022NZ-$72.74-58.63%
2021NZ-$175.85158.05%
2020NZ-$68.15